RXi Pharmaceuticals to Present at Premier Scientific Plastic Surgery Meeting -- MARLBOROUGH, Mass., Oct. 12, 2015 /PRNewswire/ --

MARLBOROUGH, Mass., Oct. 12, 2015 /PRNewswire/ --RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology, todayannounced that Dr. Robert Galiano, one of the Company's Principal Investigators for the RXI-109 clinical program, will present during The Plastic Surgery Foundation (PSF) Industry Summit. The Summit will take place on Sunday, October 18, 2015 from 3:30-4:45 p.m. EDT in Boston, Massachusetts. Dr. Galiano will present an overview of the Company's dermal clinical program with RXI-109. The presentation will be available on the "Investors" section of the Com